v3.26.1
Stockholders' Equity (Details)
 3 Months Ended 6 Months Ended
Jun. 12, 2026
shares
Jun. 11, 2026
$ / shares
shares
Apr. 07, 2026
$ / shares
shares
Aug. 01, 2025
shares
Dec. 13, 2024
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Mar. 31, 2026
shares
Jun. 30, 2025
shares
Mar. 31, 2025
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Dec. 31, 2025
shares
Shareholders’ Equity [Line Items]                      
Number of shares authorized           100,000,000       100,000,000 100,000,000
Common stock, shares issued           2,625,890       2,625,890 1,111,010
Share option granted           1,769,881        
Common stock, shares Outstanding (in Shares)           2,625,890       2,625,890 1,111,010
RSUs [Member]                      
Shareholders’ Equity [Line Items]                      
Shares issued   557,248                  
Share option granted   305,136                  
Number of shares vesting   252,112                  
RSAs [Member]                      
Shareholders’ Equity [Line Items]                      
Shares issued     134,815                
Weighted average grant date fair value | $ / shares     $ 1.64                
Restricted Stock Units and Awards [Member]                      
Shareholders’ Equity [Line Items]                      
Recognized over a weighted average period                   2 years 7 months 6 days  
Unrecognized compensation costs | $           $ 1,803,600       $ 1,803,600  
Stock Option [Member]                      
Shareholders’ Equity [Line Items]                      
Outstanding options intrinsic value | $           1,925,371       $ 1,925,371  
Recognized over a weighted average period                   3 years 1 month 6 days  
Unrecognized compensation costs | $           $ 2,980,300,000       $ 2,980,300,000  
Number of shares vesting                   252,113  
Inducement Grants [Member]                      
Shareholders’ Equity [Line Items]                      
Number of shares authorized for grant           305,136       305,136  
Share option granted 557,249                    
Exercise price | $ / shares           $ 2.98       $ 2.98  
Azora Therapeutics [Member]                      
Shareholders’ Equity [Line Items]                      
Sale of stock   1,700,000                  
2017 Equity incentive Plan [Member]                      
Shareholders’ Equity [Line Items]                      
Number of shares issued                   3,330  
Common Stock [Member]                      
Shareholders’ Equity [Line Items]                      
Common stock, shares issued           216,960       216,960  
Shares issued           544,454 181,230 216,314 3,000    
Common Stock [Member] | Stock Option [Member]                      
Shareholders’ Equity [Line Items]                      
Exchange ratio   0.00319                  
Common Stock [Member] | Former Azora Stockholders [Member]                      
Shareholders’ Equity [Line Items]                      
Common stock, shares issued           437,421       437,421  
Common Stock [Member] | Azora Therapeutics [Member]                      
Shareholders’ Equity [Line Items]                      
Common stock, shares Outstanding (in Shares)   1,177,782                  
Common Stock [Member] | 2017 Equity incentive Plan [Member]                      
Shareholders’ Equity [Line Items]                      
Common stock, shares issued           725,684       725,684  
Equity issuance cost | $                   $ 1,200,000  
At-the-Market Offering Agreement 2025 [Member]                      
Shareholders’ Equity [Line Items]                      
Sale of stock       4,983,000              
Fixed commission rate on sale of common stock       3.00%              
Standby Equity Purchase Agreement [Member]                      
Shareholders’ Equity [Line Items]                      
Sold amount | $                   $ 4,900,000  
Newly issued share         5,000,000            
Standby Equity Purchase Agreement [Member] | Common Stock [Member]                      
Shareholders’ Equity [Line Items]                      
Shares issued         2,752            
Minimum [Member]                      
Shareholders’ Equity [Line Items]                      
Number of shares authorized       50,000,000              
Exercise price per share | $ / shares   $ 0.53                  
Minimum [Member] | Azora Therapeutics [Member] | Stock Option [Member]                      
Shareholders’ Equity [Line Items]                      
Recognized over a weighted average period   3 years 10 months 24 days                  
Minimum [Member] | 2017 Equity incentive Plan [Member]                      
Shareholders’ Equity [Line Items]                      
Number of shares authorized for grant       80,000              
Maximum [Member]                      
Shareholders’ Equity [Line Items]                      
Number of shares authorized       100,000,000              
Exercise price per share | $ / shares   $ 1.57                  
Maximum [Member] | Azora Therapeutics [Member] | Stock Option [Member]                      
Shareholders’ Equity [Line Items]                      
Recognized over a weighted average period   9 months                  
Maximum [Member] | 2017 Equity incentive Plan [Member]                      
Shareholders’ Equity [Line Items]                      
Number of shares authorized for grant       200,000